Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu-Chi Chen

Showing results (181-190 of 203) with videos related to

Pageof 21
Sort By:
Molecular Medicine (Cambridge, Mass.)|December 27, 2025
A SARS-CoV-2 spike-derived adjuvant peptide boosts IL-17/IFN-γ immunity and improves anti-PD-L1 therapy against melanomaChia-Hung Chen, Tzu-Han Weng, Ta-Wei Kuo, et al.
Genes|October 11, 2019
Cholesteryl Ester Transfer Protein Genetic Variants Associated with Risk for Type 2 Diabetes and Diabetic Kidney Disease in Taiwanese PopulationYu-Chuen Huang, Shih-Yin Chen, Shih-Ping Liu, et al.
PNAS Nexus|December 19, 2025
A genome-wide RNAi screen for novel CIN genes using human artificial chromosomeMikhail Liskovykh, Natalia Y Kochanova, Chih-Yuan Chiang, et al.
Plos Pathogens|December 8, 2016
Actin-Related Protein 2 (ARP2) and Virus-Induced Filopodia Facilitate Human Respiratory Syncytial Virus SpreadMasfique Mehedi, Thomas McCarty, Scott E Martin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2003
HLA-G is a potential tumor marker in malignant ascitesGad Singer, Vera Rebmann, Yu-Chi Chen, et al.
Chinese Journal of Natural Medicines|July 4, 2020
Nagilactone E increases PD-L1 expression through activation of c-Jun in lung cancer cellsYu-Chi Chen, Mu-Yang Huang, Le-Le Zhang, et al.
Scientific Reports|March 18, 2021
A high-throughput screening to identify small molecules that suppress huntingtin promoter activity or activate huntingtin-antisense promoter activityHouda G Khaled, Hongxuan Feng, Xin Hu, et al.
Pharmacological Research|November 20, 2023
Ginsenoside Rh2 augmented anti-PD-L1 immunotherapy by reinvigorating CD8<sup>+</sup> T cells via increasing intratumoral CXCL10Mu-Yang Huang, Yu-Chi Chen, Wen-Yu Lyu, et al.
ACS Pharmacology & Translational Science|November 14, 2024
Tumor Heterogeneity Shapes Survival Dynamics in Drug-Treated Cells, Revealing Size-Drifting SubpopulationsVenugopal Vangala, Yu-Chi Chen, Saketh S Dinavahi, et al.
Journal of Neuro-Oncology|December 5, 2022
Natural history of lung squamous cell brain metastases in patients treated with radiosurgery: a thirty-year experience at a tertiary medical centerYu-Chi Chen, Huai-Che Yang, Chi-Lu Chiang, et al.
Pageof 21

Showing results (181-190 of 203) with videos related to

Sort By:
Pageof 21
Molecular Medicine (Cambridge, Mass.)|December 27, 2025
A SARS-CoV-2 spike-derived adjuvant peptide boosts IL-17/IFN-γ immunity and improves anti-PD-L1 therapy against melanomaChia-Hung Chen, Tzu-Han Weng, Ta-Wei Kuo, et al.
Genes|October 11, 2019
Cholesteryl Ester Transfer Protein Genetic Variants Associated with Risk for Type 2 Diabetes and Diabetic Kidney Disease in Taiwanese PopulationYu-Chuen Huang, Shih-Yin Chen, Shih-Ping Liu, et al.
PNAS Nexus|December 19, 2025
A genome-wide RNAi screen for novel CIN genes using human artificial chromosomeMikhail Liskovykh, Natalia Y Kochanova, Chih-Yuan Chiang, et al.
Plos Pathogens|December 8, 2016
Actin-Related Protein 2 (ARP2) and Virus-Induced Filopodia Facilitate Human Respiratory Syncytial Virus SpreadMasfique Mehedi, Thomas McCarty, Scott E Martin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2003
HLA-G is a potential tumor marker in malignant ascitesGad Singer, Vera Rebmann, Yu-Chi Chen, et al.
Chinese Journal of Natural Medicines|July 4, 2020
Nagilactone E increases PD-L1 expression through activation of c-Jun in lung cancer cellsYu-Chi Chen, Mu-Yang Huang, Le-Le Zhang, et al.
Scientific Reports|March 18, 2021
A high-throughput screening to identify small molecules that suppress huntingtin promoter activity or activate huntingtin-antisense promoter activityHouda G Khaled, Hongxuan Feng, Xin Hu, et al.
Pharmacological Research|November 20, 2023
Ginsenoside Rh2 augmented anti-PD-L1 immunotherapy by reinvigorating CD8<sup>+</sup> T cells via increasing intratumoral CXCL10Mu-Yang Huang, Yu-Chi Chen, Wen-Yu Lyu, et al.
ACS Pharmacology & Translational Science|November 14, 2024
Tumor Heterogeneity Shapes Survival Dynamics in Drug-Treated Cells, Revealing Size-Drifting SubpopulationsVenugopal Vangala, Yu-Chi Chen, Saketh S Dinavahi, et al.
Journal of Neuro-Oncology|December 5, 2022
Natural history of lung squamous cell brain metastases in patients treated with radiosurgery: a thirty-year experience at a tertiary medical centerYu-Chi Chen, Huai-Che Yang, Chi-Lu Chiang, et al.
Pageof 21